Cytomegalovirus in Solid Organ Transplant Recipients

被引：237
|
作者：
Humar, A. [1 ]
Snydman, D. [2 ]
机构：
[1] Univ Alberta, Dept Med, Transplant Infect Dis, Edmonton, AB, Canada
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
Cytomegalovirus; ganciclovir; preemptive therapy; prophylaxis; GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS; IMMUNE GLOBULIN PROPHYLAXIS; AMPLICOR CMV MONITOR; CLINICAL UTILITY; VIRAL-LOAD; ORAL GANCICLOVIR; VALGANCICLOVIR PROPHYLAXIS; INTRAVENOUS GANCICLOVIR; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION;
D O I：
10.1111/j.1600-6143.2009.02897.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S78 / S86
页数：9
相关论文
共 50 条
  • [41] Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma
    Rollag, Halvor
    Ueland, Thor
    Asberg, Anders
    Hartmann, Anders
    Jardine, Alan G.
    Humar, Atul
    Pescovitz, Mark D.
    Bignamini, Angelo A.
    Aukrust, Pal
    PLOS ONE, 2013, 8 (04):
  • [42] Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients
    Razonable, RR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 : S7 - S13
  • [43] Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients
    Oriol Manuel
    Current Infectious Disease Reports, 2013, 15 : 491 - 496
  • [44] Antiviral medications for preventing cytomegalovirus disease (CMV) in solid organ transplant recipients
    Ladhani, Maleeka
    NEPHROLOGY, 2013, 18 (03) : 237 - 238
  • [45] Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature
    Scherger, Sias
    Mathur, Swati
    Bajrovic, Valida
    Johnson, Steven C.
    Benamu, Esther
    Ramanan, Poornima
    Wolfel, Gene
    Levi, Marilyn E.
    Abidi, Maheen Z.
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (03)
  • [46] Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients
    Sabatino, David C.
    Hedvat, Jessica
    Salerno, David M.
    Pereira, Marcus R.
    Lange, Nicholas W.
    CLINICAL TRANSPLANTATION, 2023, 37 (04)
  • [47] Real World Experience with Maribavir for the Treatment of Cytomegalovirus in Solid Organ Transplant Recipients
    Sabatino, D.
    Hedvat, J.
    Salerno, D. M.
    Pereira, M.
    Lange, N. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1117 - S1117
  • [48] Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients
    Cochrane, Adam B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S17 - S21
  • [49] Current status of the prevention of cytomegalovirus disease in solid organ transplant recipients - Introduction
    Baillie, G. Mark
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S2 - S2
  • [50] Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients
    Torres-Madriz, Gilberto
    Boucher, Helen W.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (05) : 702 - 711
12345